CHIRANJEEVI BARREDDI

Dr. CHIRANJEEVI BARREDDI

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
PKPankaj Khairnar
Pankaj Khairnar
CBCHIRANJEEVI BARREDDI
CHIRANJEEVI BARREDDI
NTNakul Telang
Nakul Telang
SASaeed Ahmad
Saeed Ahmad
FGFrank Gupton
Frank Gupton
MNMichel C. Nuckols
Michel C. Nuckols
TBAJ-876 is an anti-tuberculosis drug shown to have high activity against multi-drug resistant tuberculosis (TB). We report a very efficient synthesis of the TBAJ-876 fragment 876A-B using an aldol condensation strategy starting from 6-bromo-3,4-dihydroquinolin-2(H)-one. The synthesis has been accomplished at multigram scale without the need of chromatography purification steps.